These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3511551)

  • 21. Papillary microcarcinoma of the thyroid.
    Shaha AR; Tuttle RM; Shah JP
    J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
    [No Abstract]   [Full Text] [Related]  

  • 22. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Vaisman A; Orlov S; Yip J; Hu C; Lim T; Dowar M; Freeman JL; Walfish PG
    Head Neck; 2010 Jun; 32(6):689-98. PubMed ID: 20187016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodine and radiotherapy in the management of thyroid cancers.
    Simpson WJ
    Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
    Schlumberger M; Catargi B; Borget I; Deandreis D; Zerdoud S; Bridji B; Bardet S; Leenhardt L; Bastie D; Schvartz C; Vera P; Morel O; Benisvy D; Bournaud C; Bonichon F; Dejax C; Toubert ME; Leboulleux S; Ricard M; Benhamou E;
    N Engl J Med; 2012 May; 366(18):1663-73. PubMed ID: 22551127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic
    Trevizam PG; Tagliarini JV; Castilho EC; de Alencar Marques M; Kiy Y; Mazeto GMFS
    Endocr Res; 2017 Feb; 42(1):42-48. PubMed ID: 27144920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total thyroidectomy for differentiated thyroid cancer.
    Sosa JA; Udelsman R
    J Surg Oncol; 2006 Dec; 94(8):701-7. PubMed ID: 17131393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic approach to differentiated carcinoma of the thyroid gland].
    Busnardo B
    Minerva Endocrinol; 1987; 12(1):69-73. PubMed ID: 3587203
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgery for thyroid carcinoma.
    Starnes HF; Brooks DC; Pinkus GS; Brooks JR
    Cancer; 1985 Mar; 55(6):1376-81. PubMed ID: 3971307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of differentiated thyroid carcinoma studied in 500 patients.
    Lerch H; Schober O; Kuwert T; Saur HB
    J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differentiated cancers].
    Görtz G; Häring R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():961-6. PubMed ID: 1983687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoma of the thyroid. Modalities of therapy.
    Wilson SM
    Surg Clin North Am; 1973 Feb; 53(1):169-74. PubMed ID: 4702995
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
    Miyauchi A; Kudo T; Miya A; Kobayashi K; Ito Y; Takamura Y; Higashiyama T; Fukushima M; Kihara M; Inoue H; Tomoda C; Yabuta T; Masuoka H
    Thyroid; 2011 Jul; 21(7):707-16. PubMed ID: 21649472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
    Paloyan E; Walker RP; Lawrence AM
    Surg Oncol Clin N Am; 1998 Oct; 7(4):665-80. PubMed ID: 9735128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conservative approach to treatment of thyroid cancer.
    Crile G
    Postgrad Med; 1975 Jun; 57(7):111-5. PubMed ID: 1129217
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of the plan of therapy on prognosis in thyroid cancer].
    Schümichen C; Schmitt E; Scheuffele C; Blattmann H; Pauli-Harnasch C
    Nuklearmedizin; 1983 Apr; 22(2):97-105. PubMed ID: 6866782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current state of the treatment of thyroid cancer].
    Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
    Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
    Elisei R; Schlumberger M; Driedger A; Reiners C; Kloos RT; Sherman SI; Haugen B; Corone C; Molinaro E; Grasso L; Leboulleux S; Rachinsky I; Luster M; Lassmann M; Busaidy NL; Wahl RL; Pacini F; Cho SY; Magner J; Pinchera A; Ladenson PW
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4171-9. PubMed ID: 19850694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.